The axis inhibition protein 2 (AXIN2), a member of the WNT pathway, is associated with the development and progression of breast cancers [21, 28], and polymorphisms in AXIN2 are associated with increased risk for breast cancer in premenopausal women [29]. This evidence concerns the gene AXIN2 and breast cancer.